$11.565
-0.279 (-2.41%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ZVRA Prediction & Forecast by Similar Chart Analysis
Alphio's ZVRA stock price prediction model matches the current Zevra Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.62 (+0.49%). The 1-week path is $12.10 (+4.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Zevra Therapeutics Inc Stock?
Zevra Therapeutics Inc is currently a hold due to mixed signals. The current price is $11.565, while the forward P/E ratio stands at 11.19, indicating reasonable valuation. However, the RSI is at 45.48, suggesting the stock is nearing oversold territory but not yet a strong buy signal. The recent earnings report showed a significant EPS surprise of 212.5%, with reported EPS at $0.25, which is a positive indicator. Yet, the negative opinion from the EMA regarding the drug application poses a risk, as it could impact future revenue growth. The stock has seen a 5-day change of -2.57%, reflecting recent volatility.
ZVRA stock price ended at $11.57 on Friday, after losing -2.41%
Zevra Therapeutics Inc (ZVRA) last closed at $11.565, losing -2.41%. These facts feed the 1-day and 1-week ZVRA price prediction above.
Forecast Drivers
Zevra Therapeutics Inc (ZVRA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ZVRA, ranked by similarity.
Seasonality analysis for ZVRA
Historically the probability of a positive August return for ZVRA is 92.06%. October offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ZVRA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $22.67 | $23.61 | $30.02 | +104.13% |
| Sep 2026 | $21.24 | $24.82 | $32.37 | +114.60% |
| Oct 2026 | $16.02 | $17.58 | $24.15 | +52.01% |
| Nov 2026 | $12.14 | $17.17 | $24.99 | +48.46% |
| Dec 2026 | $20.43 | $23.43 | $26.57 | +102.59% |
In 2026, Zevra Therapeutics Inc (ZVRA) is projected to range from $12.14 to $32.37.
Zevra Therapeutics Inc 2026 monthly forecast
In Aug 2026, Zevra Therapeutics Inc is projected to average $23.61, with a low of $22.67 and high of $30.02.
In Sep 2026, Zevra Therapeutics Inc is projected to average $24.82, with a low of $21.24 and high of $32.37.
In Oct 2026, Zevra Therapeutics Inc is projected to average $17.58, with a low of $16.02 and high of $24.15.
In Nov 2026, Zevra Therapeutics Inc is projected to average $17.17, with a low of $12.14 and high of $24.99.
In Dec 2026, Zevra Therapeutics Inc is projected to average $23.43, with a low of $20.43 and high of $26.57.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.